Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -126,966 | -53,839 | -212,394 | -142,494 | -85,037 |
| Depreciation Amortization | 1,468 | 753 | 116 | -660 | -577 |
| Accounts payable and accrued liabilities | 2,609 | 1,421 | -9,164 | -6,887 | -8,758 |
| Other Working Capital | -11,662 | -13,584 | -15,227 | -18,450 | -28,783 |
| Other Operating Activity | 14,221 | 6,611 | 45,750 | 25,525 | 20,699 |
| Operating Cash Flow | $-120,330 | $-58,638 | $-190,919 | $-142,966 | $-102,456 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -302,177 | N/A | 76,734 | 76,734 | -48,266 |
| PPE Investments | -5,178 | -3,002 | -9,685 | -5,686 | -4,570 |
| Other Investing Activity | -9,014 | -9,014 | -6,246 | -6,246 | -6,246 |
| Investing Cash Flow | $-316,369 | $-12,016 | $60,803 | $64,802 | $-59,082 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,287 | 229 | 679,813 | 219,236 | 172,928 |
| Other Financing Activity | -364 | -364 | -39,456 | -11,674 | -10,755 |
| Financing Cash Flow | $923 | $-135 | $640,357 | $207,562 | $162,173 |
| Beginning Cash Position | 653,692 | 653,692 | 143,451 | 143,451 | 143,451 |
| End Cash Position | 217,916 | 582,903 | 653,692 | 272,849 | 144,086 |
| Net Cash Flow | $-435,776 | $-70,789 | $510,241 | $129,398 | $635 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120,330 | -58,638 | -190,919 | -142,966 | -102,456 |
| Capital Expenditure | -5,178 | -3,002 | -9,685 | -5,686 | -4,570 |
| Free Cash Flow | -125,508 | -61,640 | -200,604 | -148,652 | -107,026 |